Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2006 Sep;29(9):2130-6.
doi: 10.2337/dc05-1973.

Disparities in HbA1c levels between African-American and non-Hispanic white adults with diabetes: a meta-analysis

Julienne K Kirk  1 , Ralph B D'Agostino Jr, Ronny A Bell, Leah V Passmore, Denise E Bonds, Andrew J Karter, K M Venkat Narayan
Affiliations
Review

Disparities in HbA1c levels between African-American and non-Hispanic white adults with diabetes: a meta-analysis

Julienne K Kirk et al. Diabetes Care. 2006 Sep.

Abstract

Objective: Among individuals with diabetes, a comparison of HbA(1c) (A1C) levels between African Americans and non-Hispanic whites was evaluated. Data sources included PubMed, Web of Science, the Cumulative Index to Nursing and Allied Health, the Cochrane Library, the Combined Health Information Database, and the Education Resources Information Center.

Research design and methods: We executed a search for articles published between 1993 and 2005. Data on sample size, age, sex, A1C, geographical location, and study design were extracted. Cross-sectional data and baseline data from clinical trials and cohort studies for African Americans and non-Hispanic whites with diabetes were included. Diabetic subjects aged <18 years and those with pre-diabetes or gestational diabetes were excluded. We conducted a meta-analysis to estimate the difference in the mean values of A1C for African Americans and non-Hispanic whites.

Results: A total of 391 studies were reviewed, of which 78 contained A1C data. Eleven had data on A1C for African Americans and non-Hispanic whites and met selection criteria. A meta-analysis revealed the standard effect to be 0.31 (95% CI 0.39-0.25). This standard effect correlates to an A1C difference between groups of approximately 0.65%, indicating a higher A1C across studies for African Americans. Grouping studies by study type (cross-sectional or cohort), method of data collection for A1C (chart review or blood draw), and insurance status (managed care or nonmanaged care) showed similar results.

Conclusions: The higher A1C observed in this meta-analysis among African Americans compared with non-Hispanic whites may contribute to disparity in diabetes morbidity and mortality in this population.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Standard effect size summary for the difference between A1C in African Americans and non-Hispanic whites. *Cross-sectional study; †data obtained from chart review; ‡A1C sample from study-initiated blood draw; §prospective cohort study or clinical trial; ‖managed care; ¶nonmanged care.
Figure 2
Figure 2
Standard effect size for the difference between A1C in African-American and non-Hispanic white men.
Figure 3
Figure 3
Standard effect size for the difference between A1C in African-American and non-Hispanic white women.
See this image and copyright information in PMC

References

    1. Cowie CC, Port FK, Wolfe RA, Savage PJ, Moll PP, Hawthorne VM. Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. N Engl J Med. 1989;321:1074–1079. - PubMed
    1. Harris MI, Klein R, Cowie CC, Rowland M, Byrd-Holt DD. Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican Americans than in non-Hispanic whites with type 2 diabetes? A U.S. population study. Diabetes Care. 1998;21:1230–1235. - PubMed
    1. Lavery LA, Ashry HR, van Houtum W, Pugh JA, Harkless LB, Basu S. Variation in the incidence and proportion of diabetes-related amputations in minorities. Diabetes Care. 1996;19:48–52. - PubMed
    1. Pugh JA, Stern MP, Haffner SM, Eifler CW, Zapata M. Excess incidence of treatment of end-stage renal disease in Mexican Americans. Am J Epidemiol. 1988;127:135–144. - PubMed
    1. Narayan KM, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF. Lifetime risk for diabetes mellitus in the United States. JAMA. 2003;290:1884–1890. - PubMed

MeSH terms

Substances